首页> 外文期刊>BMC Cancer >Regulatory dissection of the CBX5 and hnRNPA1 bi-directional promoter in human breast cancer cells reveals novel transcript variants differentially associated with HP1α down-regulation in metastatic cells
【24h】

Regulatory dissection of the CBX5 and hnRNPA1 bi-directional promoter in human breast cancer cells reveals novel transcript variants differentially associated with HP1α down-regulation in metastatic cells

机译:人类乳腺癌细胞中CBX5和hnRNPA1双向启动子的调控解剖揭示了与转移细胞中HP1α下调差异相关的新型转录物变体

获取原文
获取外文期刊封面目录资料

摘要

Background The three members of the human heterochromatin protein 1 (HP1) family of proteins, HP1α, HP1β, and HPγ, are involved in chromatin packing and epigenetic gene regulation. HP1α is encoded from the CBX5 gene and is a suppressor of metastasis. CBX5 is down-regulated at the transcriptional and protein level in metastatic compared to non-metastatic breast cancer. CBX5 shares a bi-directional promoter structure with the hnRNPA1 gene. But whereas CBX5 expression is down-regulated in metastatic cells, hnRNAP1 expression is constant. Here, we address the regulation of CBX5 in human breast cancer. Methods Transient transfection and transposon mediated integration of dual-reporter mini-genes containing the bi-directional hnRNPA1 and CBX5 promoter was performed to investigate transcriptional regulation in breast cancer cell lines. Bioinformatics and functional analysis were performed to characterize transcriptional events specifically regulating CBX5 expression. TSA treatment and Chromatin Immunoprecipitation (ChIP) were performed to investigate the chromatin structure along CBX5 in breast cancer cells. Finally, expression of hnRNPA1 and CBX5 mRNA isoforms were measured by quantitative reverse transcriptase PCR (qRT-PCR) in breast cancer tissue samples. Results We demonstrate that an hnRNPA1 and CBX5 bi-directional core promoter fragment does not comprise intrinsic capacity for specific CBX5 down-regulation in metastatic cells. Characterization of transcriptional events in the 20?kb CBX5 intron 1 revealed existence of several novel CBX5 transcripts. Two of these encode consensus HP1α protein but used autonomous promoters in intron 1 by which HP1α expression could be de-coupled from the bi-directional promoter. In addition, another CBX5 transcriptional isoform, STET , was discovered. This transcript includes CBX5 exon 1 and part of intron 1 sequences but lacks inclusion of HP1α encoding exons. Inverse correlation between STET and HP1α coding CBX5 mRNA expression was observed in breast cancer cell lines and tissue samples from breast cancer patients. Conclusion We find that HP1α is down-regulated in a mechanism involving CBX5 promoter downstream sequences and that regulation through alternative polyadenylation and splicing generates a transcript, STET, with potential importance in carcinogenesis.
机译:背景技术人异染色质蛋白1(HP1)家族的三个成员HP1α,HP1β和HPγ参与染色质的包装和表观遗传基因的调控。 HP1α由CBX5基因编码,是转移的抑制因子。与非转移性乳腺癌相比,CBX5在转移性蛋白的转录和蛋白水平上被下调。 CBX5与hnRNPA1基因共享双向启动子结构。但是,尽管CBX5表达在转移细胞中被下调,但hnRNAP1表达却是恒定的。在这里,我们探讨人类乳腺癌中CBX5的调控。方法进行瞬时转染和转座子介导的包含双向hnRNPA1和CBX5双向启动子的双报告子小基因整合,以研究乳腺癌细胞系中的转录调控。进行了生物信息学和功能分析,以表征专门调节CBX5表达的转录事件。进行了TSA处理和染色质免疫沉淀(ChIP),以研究乳腺癌细胞中沿CBX5的染色质结构。最后,通过定量逆转录酶PCR(qRT-PCR)测定了乳腺癌组织样品中hnRNPA1和CBX5 mRNA的亚型的表达。结果我们证明hnRNPA1和CBX5双向核心启动子片段不包含转移细胞中特定CBX5下调的内在能力。在20kb CBX5内含子1中转录事件的表征揭示了几种新颖的CBX5转录本的存在。这些中的两个编码共有HP1α蛋白,但在内含子1中使用了自主启动子,通过该启动子可以将HP1α表达与双向启动子解偶联。此外,发现了另一种CBX5转录同工酶STET。该转录本包含CBX5外显子1和部分内含子1序列,但缺少HP1α编码外显子。在乳腺癌细胞系和乳腺癌患者的组织样本中观察到STET与编码CBX5 mRNA的HP1α之间呈负相关。结论我们发现HP1α在涉及CBX5启动子下游序列的机制中被下调,并且通过交替的多聚腺苷酸化和剪接产生的转录产生转录本STET,其在致癌作用中具有潜在的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号